<div align="center">

# ğŸ”¬ multimorbidity-SEM

### Decoding Multimorbidity: Cancers, Cardiovascular & Inflammatory Chronic Diseases

[![License: GPL v3](https://img.shields.io/badge/License-GPLv3-blue.svg)](https://choosealicense.com/licenses/gpl-3.0/)
[![Python 3.8+](https://img.shields.io/badge/python-3.8%2B-blue.svg)](https://www.python.org/)
[![Stata 17+](https://img.shields.io/badge/Stata-17%2B-1a5276?logo=data:...&logoColor=white)](https://www.stata.com/)
[![Status: Submitted](https://img.shields.io/badge/status-submitted-orange.svg)]()
[![Open In Colab](https://colab.research.google.com/assets/colab-badge.svg)](https://colab.research.google.com/github/MorillaLab/multimorbidity-SEM/blob/main/analysis/01_data_cleaning.ipynb)

**The first mathematical demonstration** of interconnected pathophysiological links between familial cardiovascular risk, inflammaging, cancer, and chronic inflammatory diseases â€” using Structural Equation Modelling on a 677-patient prospective cohort.

[ğŸ“„ Paper](#-citation) Â· [ğŸš€ Quick Start](#-quick-start) Â· [ğŸ“Š Key Findings](#-key-findings) Â· [ğŸ—ï¸ Model](#ï¸-sem-framework) Â· [ğŸ—‚ï¸ Data](#ï¸-data-availability)

</div>

---

## ğŸ” Overview

Multimorbidity â€” the co-occurrence of multiple chronic conditions â€” is one of the leading challenges in modern medicine. Yet the pathophysiological pathways linking cancers, cardiovascular disease, and inflammatory conditions remain poorly understood.

This study applies **Structural Equation Modelling (SEM)** to a prospective cohort of 677 cancer patients followed at HÃ´pital Avicenne (APHP, Paris) from 2016 to 2022. We construct and validate latent variables capturing *Inflammaging*, *Familial Cancer Risk*, *Familial Vascular Risk*, and *Early Chronic Disease* â€” and trace their causal pathways to metastatic disease and mortality.

**Key contributions:**
- First mathematical proof of shared constitutional pathways between familial cardiovascular risk, inflammaging, and cancer
- Identification of sex-specific causal mechanisms in women
- Fully validated SEM models with excellent fit (CFI up to 0.926; RMSEA as low as 0.043)
- Open, reproducible analysis pipeline in Python + Stata

<p align="center">
  <img src="figures/Figure_1.jpg" alt="Theoretical SEM framework" width="800"/>
  <br/>
  <em>Figure 1 â€” Theoretical model. Orange ellipses: latent variables; green rectangles: observed variables.<br/>
  Solid blue arrows: direct paths; dashed red arrows: hypothesized outcome pathways.</em>
</p>

---

## ğŸ“Š Key Findings

| Finding | Detail |
|---|---|
| **Inflammaging â†’ Cancer** | Strong factor loading (Î² = 0.80); sex, smoking, BMI as core indicators |
| **Familial Vascular Risk â†’ Cancer Risk** | Significant cross-domain association, suggesting shared genetic pathways |
| **Sex-specific mortality pathways** | In women: Inflammaging â†’ mortality directly (not mediated); familial risk â†’ metastasis â†’ death |
| **Model fit (best model)** | CFI = 0.926 Â· RMSEA = 0.043 Â· SRMR < 0.08 |
| **Cohort** | n = 677 cancer patients Â· median follow-up 2.14 â€“ 3.03 yrs |

---

## ğŸ—ï¸ SEM Framework

Four latent variables were constructed and validated across four models:

| Latent Variable | Observed Indicators |
|---|---|
| ***Inflammaging*** | Sex, Smoking (packÂ·year), BMI |
| ***Familial Cancer Risk*** | Familial cancer history, Early familial cancer |
| ***Familial Vascular Risk*** | Familial CVD, Early familial CVD, Familial CVRF, Early CVRF |
| ***Early Chronic Disease*** | Early AID, Severe AID, Early CVD, Early CVRF |

Models were estimated by **maximum likelihood** in Stata 17. Fit was assessed using CFI, RMSEA, and SRMR thresholds (CFI > 0.90, RMSEA < 0.06, SRMR < 0.08).

---

## ğŸš€ Quick Start

### Installation

```bash
git clone https://github.com/MorillaLab/multimorbidity-SEM.git
cd multimorbidity-SEM
pip install -r requirements.txt
```

### Run the analysis pipeline

```bash
# Step 1 â€” Data cleaning & iterative imputation
python analysis/01_data_cleaning.py

# Step 2 â€” Descriptive statistics (Tables 1 & 2)
python analysis/02_descriptive_stats.py

# Step 3 â€” CramÃ©r's V correlation matrix
python analysis/03_correlation_matrix.py

# Step 4 â€” SEM models (requires Stata 17+)
# Open analysis/04_sem_models.do in Stata and run all
```

### Reproduce a specific figure

```python
import pandas as pd
import matplotlib.pyplot as plt
from analysis.correlation_matrix import plot_cramers_v

df = pd.read_csv("data/cohort_cleaned.csv")
fig = plot_cramers_v(df)
fig.savefig("figures/correlation_matrix.pdf", dpi=300)
```

---

## ğŸ“ Repository Structure

```
multimorbidity-SEM/
â”œâ”€â”€ analysis/
â”‚   â”œâ”€â”€ 01_data_cleaning.py          # Preprocessing & iterative imputation
â”‚   â”œâ”€â”€ 02_descriptive_stats.py      # EDA â€” Table 1 & Table 2
â”‚   â”œâ”€â”€ 03_correlation_matrix.py     # CramÃ©r's V heatmap
â”‚   â””â”€â”€ 04_sem_models.do             # SEM construction (Stata, Models 1â€“4)
â”œâ”€â”€ data/
â”‚   â””â”€â”€ README.md                    # Variable definitions & availability statement
â”œâ”€â”€ figures/
â”‚   â”œâ”€â”€ README.md                    # Figure legends & generation notes
â”‚   â””â”€â”€ Figure_1.jpg                 # Theoretical SEM framework
â”œâ”€â”€ results/
â”‚   â””â”€â”€ README.md                    # Output descriptions & model fit summary
â”œâ”€â”€ SEM ARTICLE/                     # Manuscript-related materials
â”œâ”€â”€ Figure1.png                      # Root-level figure copy
â”œâ”€â”€ requirements.txt                 # Python dependencies
â”œâ”€â”€ CITATION.cff                     # Citation metadata
â””â”€â”€ LICENSE                          # GPL-3.0
```

---

## ğŸ¥ Study Design

| Parameter | Value |
|---|---|
| **Design** | Prospective monocentric cohort |
| **Site** | HÃ´pital Avicenne, APHP, Bobigny, France |
| **Period** | January 2016 â€“ December 2022 |
| **N** | 677 adult cancer patients |
| **Median follow-up** | 2.14 yrs (Model 1) Â· 3.03 yrs (Model 2) |
| **Primary endpoint** | All-cause mortality |
| **Secondary endpoint** | Metastatic disease |

---

## ğŸ—‚ï¸ Data Availability

De-identified data supporting this study are available from the corresponding author upon reasonable request, pending ethical approvals.

**Contact:** Prof. Guilhem Bousquet â€” [guilhem.bousquet@aphp.fr](mailto:guilhem.bousquet@aphp.fr) Â· ORCID: [0000-0001-5594-6694](https://orcid.org/0000-0001-5594-6694)

---

## ğŸ‘¥ Authors & Affiliations

| Author | Affiliation |
|---|---|
| Kelly Larissa Vomo Donfack | UniversitÃ© Sorbonne Paris Nord, LAGA, CNRS UMR 7539 & IHSM UMA-CSIC, MÃ¡laga, Spain |
| Burak GÃ¶nÃ¼llu | Faculty of Medicine, Yeditepe University, Istanbul, Turkey |
| FrÃ©dÃ©ric Pamoukjian | HÃ´pital Avicenne, APHP, Service de GÃ©riatrie |
| Eurydice Angeli | HÃ´pital Avicenne, APHP, Service d'Oncologie mÃ©dicale |
| GrÃ©gory Ginot | UniversitÃ© Sorbonne Paris Nord, LAGA, CNRS UMR 7539 |
| Ian Morillaâ€  | UniversitÃ© Sorbonne Paris Nord, LAGA, CNRS UMR 7539 & IHSM UMA-CSIC |
| Guilhem Bousquetâ€ â˜… | UnitÃ© SynKoMIC, UniversitÃ© Sorbonne Paris Nord & HÃ´pital Avicenne, APHP |
| GÃ©raldine Falgaroneâ€  | UnitÃ© SynKoMIC, UniversitÃ© Sorbonne Paris Nord & HÃ´pital Avicenne, APHP |

â€ co-senior authorship Â· â˜…corresponding author

---

## ğŸ’° Funding

No external funding. Kelly Larissa Vomo Donfack received a Ph.D. grant from Sorbonne Paris Nord University.

## âš–ï¸ Conflict of Interest

The authors declare no conflict of interest.

---

## ğŸˆ Citation

If you use this code or data in your work, please cite:

```bibtex
@article{VomoDonfack2026multimorbidity,
  author  = {Vomo Donfack, Kelly Larissa and GÃ¶nÃ¼llu, Burak and Pamoukjian, FrÃ©dÃ©ric
             and Angeli, Eurydice and Ginot, GrÃ©gory and Morilla, Ian
             and Bousquet, Guilhem and Falgarone, GÃ©raldine},
  title   = {Decoding multimorbidity: Understanding cancers, inflammatory chronic
             diseases contribution to death},
  journal = {submitted},
  year    = {2026}
}
```

---

## ğŸ¤ Contributing

We welcome contributions. Please open an issue before submitting a pull request. See [`CONTRIBUTING.md`](CONTRIBUTING.md) for guidelines.

---

## ğŸ“œ License

This project is licensed under the GNU General Public License v3.0 â€” see [`LICENSE`](LICENSE) for details.

> **Note:** The license badge in the original README incorrectly stated MIT â€” this repo uses GPL-3.0 as declared in the `LICENSE` file.

---

<div align="center">
  Made with â¤ï¸ by <a href="https://github.com/MorillaLab">MorillaLab</a>
</div>

